The average one-year price target for NeoGenomics (NasdaqCM:NEO) has been revised to $12.44 / share. This is an increase of 21.45% from the prior estimate of $10.25 dated November 7, 2025. The price ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
Throughout its cycle, NEO has aligned closely with the Adhishthana Principles, our proprietary model that blends behavioral archetypes with quantitative signals. One of the best examples of this was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results